Flu drug stockpiles save lives, too costly for many

Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic, but is too expensive for around two thirds of the world's population, scientists said on Wednesday. Researchers from Singapore found that stockpiling flu drugs such as Roche's <ROG.VX> Tamiflu and GlaxoSmithKline's Relenza "significantly reduced" death rates, but said many nations cannot afford to build up stockpiles at current prices.